CrossrefInfokarte
Impact of Molecular and Cytogenetic Risk Stratification, Early Treatment Response, and Inflammatory Biomarkers on Survival in Intensively Treated Non-Acute Promyelocytic Leukemia Acute Myeloid Leukemia
World Journal of Oncology · 2026-12 · 17 (6) · 886-897
DOI: 10.14740/wjon2856 ↗Abstract
Kein Abstract verfügbar.
EUVIMED